Jamshid Tabeshpour, Mohammad Reza Zirak, Houshang Mirakhorli, Bibi Sedigheh Fazly Bazzaz, Monavar Afzalaghaee, Mohammad Amin Kerachian, Saeid Eslami, Zhila Taherzadeh


Objective: Healthcare providers play a key role in reducing medication errors and improving patient care, especially for those who suffer with chronic diseases. This study aims to assess pharmacist attitudes toward collaborative practice in northeastern Iran.

Methods: A face-to-face survey was offered to a sample of 124 pharmacists in Mashhad, Iran, and some other cities of the Razavi Khorasan province. This survey assessed the following elements of community pharmacists’ collaborative behavior: “interactional determinants,” “environmental determinants,” and “pharmacist determinants.” Results were analyzed to determine how pharmacists’ attitudes and other variables would influence their collaborative behavior.

Results: The survey response rate was 100%. Principal component analysis revealed that the attitudes towards collaboration instrument for pharmacists (ATCI-P) in our sample consisted of two factors: interactional determinants and pharmacist determinants, both with high internal consistency (Cronbach’s alpha = 0.83). The lowest and the highest scores in the interactional determinants domain were 19 and 35, respectively. The higher attitudes toward collaboration were obtained in the capital city, Mashhad, rather than in towns (P-value = 0.006). Multiple linear regression analysis of the complete model was significant (R = 0.36, P-value = 0.005). The age and city/community size were also found to be significant predictors of collaboration behavior (B = 0.300, p = 0.002 and B = 0.259, p = 0.004, respectively).

Conclusion: The community pharmacists in Razavi Khorasan, Iran, have a profound attitude toward collaboration with physicians, and their collaborative behavior is influenced by the age and community size.


community pharmacists, attitude, collaboration, physician, ATCI-P, Iran

| PDF | HTML |


Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.

Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008;28:421-36.

Tsuyuki RT, Johnson JA, Teo KK. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The study of cardiovascular risk intervention by pharmacists (scrip). Arch Intern Med 2002;162:1149-55.

Abdelhamid E, Awad A, Gismallah A. Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients. Pharm Pract (Granada) 2008;6:25-32.

Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis 2002;12:392-7.

Kandasamy K, Natarajan A, Sebastian J, Konakalla M, Sam R, Rajagopal SS, et al. Impact of pharmacist intervention in screening and education on blood pressure in a rural area in Southern India. Asian J Pharm Clin Res 2016;9:339-43.

Chung WW, Chua SS, Lai PSM, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence 2014;8:1185-94.

George AK, Jewel VG, Manohar M, Kumar SP, Muneerudeen J. Impact of patient counselling on knowledge, attitude, practices of patients with type 2 diabetes mellitus at a tertiary care teaching hospital. Asian J Pharm Clin Res 2017;10:293-6.

Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med 1999;159:1939-45.

Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.

Taylor C, Byrd D, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003;60:1123-9.

Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004;116:394-401.

Williams ME, Pulliam CC, Hunter R, Johnson TM, Owens JE, Kincaid J, et al. The short‐term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc 2004;52:93-8.

Mohammed SI, Al-Razaq AFA. Knowledge and attitude of Iraqi pharmacists in Baghdad community toward adverse drug reactions monitoring. Asian J Pharm Clin Res 2017;10:219-22.

Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Br Med J 2001;323:1340.

Umar NF, Joel JJ, Sharma R, Shastry CS, Adepu R. Significant role of clinical pharmacists in the assessment of inappropriate medications prescribed to the elderly patients in a university teaching hospital. Asian J Pharm Clin Res 2015;8:109-12.

McDonough R, Doucette W. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc 2001;41:682-92.

Organization WH. Framework for action on interprofessional education and collaborative practice. Geneva: World Health Organization; 2010.

Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med 2008;23:1966-72.

Amariles P, Sabater-Hernandez D, Garcia-Jimenez E, Rodriguez-Chamorro MA, Prats-Mas R, Marin-Magan F, et al. Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial. J Manag Care Pharm 2012;18:311-23.

Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 2004;38:764-70.

Van C, Costa D, Mitchell B, Abbott P, Krass I. Development and initial validation of the pharmacist frequency of interprofessional collaboration instrument (FICI-P) in primary care. Res Social Adm Pharm 2012;8:397-407.

Doucette WR, Nevins J, McDonough RP. Factors affecting collaborative care between pharmacists and physicians. Res Social Adm Pharm 2005;1:565-78.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186-91.

Telmo C, Lousada J, Moreira N. Proximate analysis, backwards stepwise regression between gross calorific value, ultimate and chemical analysis of wood. Bioresour Technol 2010;101:3808-15.

Bradley EH, Byam P, Alpern R, Thompson JW, Zerihun A, Abeb Y, et al. A systems approach to improving rural care in Ethiopia. PLoS One 2012;7:e35042.

Irons BK, Meyerrose G, Laguardia S, Hazel K, Seifert CF. A collaborative cardiologist-pharmacist care model to improve hypertension management in patients with or at high risk for cardiovascular disease. Pharm Pract (Granada) 2012;10:25-32.

Dieleman SL, Farris KB, Feeny D, Johnson JA, Tsuyuki RT, Brilliant S. Primary health care teams: team members' perceptions of the collaborative process. J Interprof Care 2004;18:75-8.

Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Jackson A, et al. Physician‐pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy 2003;23:209-16.

Baran RW, Crumlish K, Patterson H, Shaw J, Erwin WG, Wylie JD, et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm 1999;56:1535-9.

Bluml BM, McKenney JM, Cziraky MJ, Elswick Jr R. Pharmaceutical care services and results in project ImPACT: Hyperlipidemia. J Am Pharm Assoc (Wash) 2000;40:157-65.

Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL, et al. Collaborative care model to improve outcomes in major depression. Ann Pharmacother 2002;36:585-91.

Swan JE, Trawick IF, Silva DW. How industrial salespeople gain customer trust. Industrial Marketing Management 1985;14:203-11.

Swan JE, Trawick IF. Building customer trust in the industrial salesperson: process and outcomes. Adv Business Marketing 1987;2:81-113.

Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2009:Cd000072.

Kelly DV, Bishop L, Young S, Hawboldt J, Phillips L, Keough TM. Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott) 2013;146:218-26.

About this article




community pharmacists, attitude, collaboration, physician, ATCI-P, Iran





Additional Links

Manuscript Submission


International Journal of Pharmacy and Pharmaceutical Sciences
Vol 9, Issue 12, 2017 Page: 212-217

Online ISSN


Authors & Affiliations

Jamshid Tabeshpour
Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Iran, Islamic Republic of

Mohammad Reza Zirak
Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Houshang Mirakhorli
Targeted Drug Delivery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Bibi Sedigheh Fazly Bazzaz
Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Monavar Afzalaghaee
Management & Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran

Mohammad Amin Kerachian
Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Saeid Eslami
Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Zhila Taherzadeh
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Article Tools


  • There are currently no refbacks.